Works matching IS 10837159 AND DT 2025 AND VI 30 AND IP 1
Results: 32
Is it time to retire preoperative radiation for localized esophageal and gastro-esophageal adenocarcinoma?
- Published in:
- Oncologist, 2025, v. 30, n. 1, p. 1, doi. 10.1093/oncolo/oyae371
- By:
- Publication type:
- Article
Liver transplantation for colorectal cancer with liver metastases.
- Published in:
- Oncologist, 2025, v. 30, n. 1, p. 1, doi. 10.1093/oncolo/oyae367
- By:
- Publication type:
- Article
The Oncologist turns thirty.
- Published in:
- Oncologist, 2025, v. 30, n. 1, p. 1, doi. 10.1093/oncolo/oyae365
- By:
- Publication type:
- Article
Ovarian clear cell carcinoma: open questions on the management and treatment algorithm.
- Published in:
- Oncologist, 2025, v. 30, n. 1, p. 1, doi. 10.1093/oncolo/oyae325
- By:
- Publication type:
- Article
Pembrolizumab ± paricalcitol in metastatic pancreatic cancer postmaximal cytoreduction.
- Published in:
- Oncologist, 2025, v. 30, n. 1, p. 1, doi. 10.1093/oncolo/oyae323
- By:
- Publication type:
- Article
A phase II study of ramucirumab and somatostatin analog therapy in patients with advanced neuroendocrine tumors.
- Published in:
- Oncologist, 2025, v. 30, n. 1, p. 1, doi. 10.1093/oncolo/oyae364
- By:
- Publication type:
- Article
Real-world use of pemigatinib for the treatment of cholangiocarcinoma in the US.
- Published in:
- Oncologist, 2025, v. 30, n. 1, p. 1, doi. 10.1093/oncolo/oyae204
- By:
- Publication type:
- Article
Phase I study of intratumoral injection of talimogene laherparepvec for the treatment of advanced pancreatic cancer.
- Published in:
- Oncologist, 2025, v. 30, n. 1, p. 1, doi. 10.1093/oncolo/oyae200
- By:
- Publication type:
- Article
Molecular tumor board: molecularly adjusted therapy upon identification and functional validation of a novel ALK resistance mutation in a case of lung adenocarcinoma.
- Published in:
- Oncologist, 2025, v. 30, n. 1, p. 1, doi. 10.1093/oncolo/oyae143
- By:
- Publication type:
- Article
Correction to: Clinical and economic impact of pharmacist interventions to identify drug-related problems in multidisciplinary cancer care: a prospective trial.
- Published in:
- 2025
- Publication type:
- Correction Notice
Steroid-refractory immune mediated hepatitis managed with budesonide in patients with metastatic melanoma: proof of concept and literature review.
- Published in:
- Oncologist, 2025, v. 30, n. 1, p. 1, doi. 10.1093/oncolo/oyae361
- By:
- Publication type:
- Article
Radiotherapy and surgery: can this combination be further optimized for patients with metastatic spine disease?
- Published in:
- Oncologist, 2025, v. 30, n. 1, p. 1, doi. 10.1093/oncolo/oyae359
- By:
- Publication type:
- Article
Pooled safety analysis and management of sotorasib-related adverse events in KRAS G12C-mutated advanced non-small cell lung cancer.
- Published in:
- Oncologist, 2025, v. 30, n. 1, p. 1, doi. 10.1093/oncolo/oyae356
- By:
- Publication type:
- Article
Correction to: Quality of life in women with early-stage and metastatic hormone receptor-positive, HER2-negative breast cancer receiving endocrine therapy.
- Published in:
- 2025
- Publication type:
- Correction Notice
Machine learning models for predicting postoperative peritoneal metastasis after hepatocellular carcinoma rupture: a multicenter cohort study in China.
- Published in:
- Oncologist, 2025, v. 30, n. 1, p. 1, doi. 10.1093/oncolo/oyae341
- By:
- Publication type:
- Article
Precision medicine: an intrahepatic cholangiocarcinoma with a novel RBPMS-MET fusion sensitive to crizotinib.
- Published in:
- Oncologist, 2025, v. 30, n. 1, p. 1, doi. 10.1093/oncolo/oyae340
- By:
- Publication type:
- Article
Clinical and molecular characteristics of patients with brain metastasis secondary to pancreatic ductal adenocarcinoma.
- Published in:
- Oncologist, 2025, v. 30, n. 1, p. 1, doi. 10.1093/oncolo/oyae182
- By:
- Publication type:
- Article
Association of opioid use with survival in patients with cancer treated with immune checkpoint inhibitors: it is time for evidence-based behaviors.
- Published in:
- Oncologist, 2025, v. 30, n. 1, p. 1, doi. 10.1093/oncolo/oyae081
- By:
- Publication type:
- Article
A first-in-human study of JNJ-70218902, a bispecific T-cell-redirecting antibody against TMEFF2 in metastatic castration-resistant prostate cancer.
- Published in:
- Oncologist, 2025, v. 30, n. 1, p. 1, doi. 10.1093/oncolo/oyae313
- By:
- Publication type:
- Article
Feasibility and acceptability of a mindfulness app-based intervention among patients with metastatic renal cell carcinoma: a multinational study.
- Published in:
- Oncologist, 2025, v. 30, n. 1, p. 1, doi. 10.1093/oncolo/oyae309
- By:
- Publication type:
- Article
Next-generation sequencing-based evaluation of the actionable landscape of genomic alterations in solid tumors: the "MOZART" prospective observational study.
- Published in:
- Oncologist, 2025, v. 30, n. 1, p. 1, doi. 10.1093/oncolo/oyae206
- By:
- Publication type:
- Article
Immune checkpoint inhibitor infusion times and clinical outcomes in patients with melanoma.
- Published in:
- Oncologist, 2025, v. 30, n. 1, p. 1, doi. 10.1093/oncolo/oyae197
- By:
- Publication type:
- Article
Novel anti-HER2 ADCs vs dual anti-HER2 antibody for HER2-positive metastatic breast cancer failed to tyrosine kinase inhibitor.
- Published in:
- Oncologist, 2025, v. 30, n. 1, p. 1, doi. 10.1093/oncolo/oyae144
- By:
- Publication type:
- Article
Pegylated liposomal doxorubicin in partially platinum-sensitive, platinum-resistant, or platinum-refractory ovarian cancer: a prospective study.
- Published in:
- Oncologist, 2025, v. 30, n. 1, p. 1, doi. 10.1093/oncolo/oyae194
- By:
- Publication type:
- Article
Dramatic response to crizotinib through MET phosphorylation inhibition in rare TFG-MET fusion advanced squamous cell lung cancer.
- Published in:
- Oncologist, 2025, v. 30, n. 1, p. 1, doi. 10.1093/oncolo/oyae166
- By:
- Publication type:
- Article
Impact of HER2-targeted PET/CT imaging in patients with breast cancer and therapeutic response monitoring.
- Published in:
- Oncologist, 2025, v. 30, n. 1, p. 1, doi. 10.1093/oncolo/oyae188
- By:
- Publication type:
- Article
Immune-related encephalitis after immune checkpoint inhibitor therapy.
- Published in:
- Oncologist, 2025, v. 30, n. 1, p. 1, doi. 10.1093/oncolo/oyae186
- By:
- Publication type:
- Article
Treatment patterns for patients with BRCA1/2-positive metastatic castration-resistant prostate cancer.
- Published in:
- Oncologist, 2025, v. 30, n. 1, p. 1, doi. 10.1093/oncolo/oyae183
- By:
- Publication type:
- Article
Prolonged complete response to adjuvant tepotinib in a patient with newly diagnosed disseminated glioblastoma harboring mesenchymal-epithelial transition fusion.
- Published in:
- Oncologist, 2025, v. 30, n. 1, p. 1, doi. 10.1093/oncolo/oyae100
- By:
- Publication type:
- Article
Primary Resistance to RET Inhibition in a RET Fusion-Positive Pancreatic Neuroendocrine Carcinoma.
- Published in:
- Oncologist, 2025, v. 30, n. 1, p. 1, doi. 10.1093/oncolo/oyae034
- By:
- Publication type:
- Article
Anaplastic Lymphoma Kinase (ALK) Inhibitors Show Activity in Colorectal Cancer With ALK Rearrangements: Case Series and Literature Review.
- Published in:
- Oncologist, 2025, v. 30, n. 1, p. 1, doi. 10.1093/oncolo/oyae020
- By:
- Publication type:
- Article
Oncofusions – shaping cancer care.
- Published in:
- Oncologist, 2025, v. 30, n. 1, p. 1, doi. 10.1093/oncolo/oyae126
- By:
- Publication type:
- Article